AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Amoxicillin + Clavulanic Acid in Zambia
5 products registered with ZAMRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Amoxiclav-Denk 500/62.5 Film Coated Tablets | 130/062 | Denk Pharma GmbH & Co. KG | active | 1 Jul 2030 |
| Koact 375 tablets Tablet Uncoated | 127/068 | Aurobindo Pharma Limited | active | 9 Mar 2030 |
| Koact 1000 tablets Film-coated Tablets | 127/070 | Aurobindo Pharma Limited | active | 8 Mar 2030 |
| Amoxiclav-Denk 1000/125 tablets Film Coated Tablets | 130/075 | Denk Pharma GmbH & Co. KG | active | 28 May 2029 |
| Koact 625 tablets Film-coated Tablets | 127/069 | Aurobindo Pharma Limited | active | 22 Feb 2027 |
Amoxicillin + Clavulanic Acid — ZAMRA Registration Details
ZAMRA (Zambia) has 5 registered products containing Amoxicillin + Clavulanic Acid, of which 5 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Amoxicillin + Clavulanic Acid registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.